Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4945 total record number 317 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 490 out of 495
4945 citations found

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice

Wang L, Harrington L, Trebicka E, Shi HN, Kagan JC, Hong CC, Lin HY, Babitt JL, Cherayil BJ

Product: Unspecified List Labs LPS

  • Macrophage stimulation:

    Thioglycollate-elicited peritoneal macrophages were prepared as previously described (25, 41) and stimulated with 100 ng/ml LPS (Ultra-pure; List Biological Laboratories), …

    Author did not specify which List Labs LPS product was utilized in their research.  List Labs provides the following LPS products:  https://listlabs.com/product-information/lipopolysaccharides/

Sensitive, In Vitro, Bifunctional, Potency Assay For Botulinum Neurotoxin Type A

Christian, T.; Shine, N.

Product: SNAPtide® Peptide Substrate (o-Abz/Dnp) for C. botulinum Type A Neurotoxin

  • Materials:

    SNAPtide substrate #520 contains the FRET pair o-aminobenzoic acid/2,4 dinitrophenyl (o-Abz/Dnp) and SNAPtidesubstrate Mca/Dnp contains (7methoxy-coumarin-4-yl)acetyl/2,4 dinitrophenyl as its FRET pair. Botulinum Neurotoxin Type A (Product #130A) and the SNAPtidesubstrates are products of List Biological Laboratories.

FRET Peptide Substrates for BotulinumNeurotoxins Types A, B, C, and E

Shine, N.; Endrukaite,E.; Christian, T.

Product: VAMPtide® Peptide Substrate (o-Abz/Dnp) Substrate for C. botulinum Type B Neurotoxin

Kinetics of Lethal Factor and Poly-D-Glutamic Acid Antigenemia during Inhalation Anthrax in Rhesus Macaques

Boyer AE, Quinn CP, Hoffmaster AR, Kozel TR, Saile E, Marston CK, Percival A, Plikaytis BD, Woolfitt AR, Gallegos M, Sabourin P, McWilliams LG, Pirkle JL, Barr JR

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

  • LF quantification:

    … To achieve the necessary dynamic range and to account for high-sensitivity rapid-response sample analysis, two standard curves were prepared, one for 20 ng/ml, l (low volume [LV]) and the other for 200 ng/ml, l (high volume [HV]) serum volumes. In addition, three quality control samples (QCs) were prepared in human serum pools (Interstate Blood Bank, Memphis, TN) using recombinant LF (List Biological Laboratory, Campbell, CA) and validated. …

    PA antigen capture immunoassay:

    Microtiter plates (Thermo Labsystems, Franklin, MA) were coated with monoclonal anti-PA antibody AVR1046 obtained by the same methodologies used for anti-LF monoclonal described previously (4) at 1.28 g/ml in 0.01 M phosphate-buffered saline (PBS), pH 7.4. Coated plates were washed with a wash buffer consisting of PBS and 0.1% Tween 20, pH 7.4. Recombinant PA (rPA; List Biological Laboratories, Inc., Campbell, CA) was serially diluted twofold using a 1/25 or a 1/100 dilution of normal rhesus macaque serum (RMS). The rPA dilutions formed a seven-point standard curve from 0.6 to 37.5 ng/ml. …

    Author did not indicate which specific lethal factor was utilized.  List Labs provides Product #172 (Anthrax Lethal Factor (LF), Recombinant from B. anthracis) and Product #169 (Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence).

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • Tracer injections

    Several minutes after being given intraperitoneal injections of a cocktail, consisting of 45% ketamine (100mg/ml), 35% xylazine (20mg/ml) and 20% physiological saline at a dose of 0.16 ml/100g of body weight, rats were placed into a Kopf stereotaxic instrument. The skulls were exposed and small bore holes were created to allow selected brain structures to be targeted by filament-containing borosilicate glass pipettes (O.D. – 1.0 mm) pulled to tip diameters of 10–25 μm and containing the retrograde tracers Fluoro-Gold (FG; Fluorochrome, Inc., Englewood, CO; 1% in 0.1M cacodylate buffer, pH 7.4) or cholera toxin B subunit (CtB, List Biological Laboratories, Campbell, CA),

    Product #104 – Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Intranasal Delivery of Cholera Toxin Induces Th17-Dominated T-Cell Response to Bystander Antigens

Jee-Boong Lee, Ji-Eun Jang, Man Ki Song, Jun Chang

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Reagents:

    CT and CTB were purchased from List Biological Laboratories (Campbell, CA). …

    Immunization:

    For peptide immunization, 26106 OT-II splenocytes were i.v. injected into B6 mice, and then recipient mice were i.n. immunized with 40 mg of OVA peptide plus 30 mg of CpG ODN, 0.2 mg of CT, or 2 mg of CT or CTB in PBS. …

    Cytokine assays:

    Dendritic cells (DCs) were generated from bone marrow of B6 or BALB/c mice by culturing in complete RPMI medium containing 10% FBS supplemented with 10 ng/ml recombinant GM-CSF and IL-4 (R&D, Minneapolis, MN). After 7 days of culture, non-adherent cells were harvested by gentle pipetting, and DCs were enriched by density gradient centrifugation over Percoll medium. After purification, DCs were further incubated with PBS or CT (100 ng/ml) for 3 days and the culture supernatants were harvested at the indicated time points. …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae
    Product #104 – Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Product: Unspecified List Labs LPS

  • Reagents:

    LPS lyophilized powder (List Biological Labs) was dissolved and diluted in phosphate buffered saline (PBS). As lethality varied among lots of LPS, when a lethal dose of LPS was desired for challenge, each lot of LPS was tested for LD50 before each experiment by injecting nave mice with varying doses of LPS (510 mice per dose group) and assessing survival. The lowest dose that yielded 80100% death was used for the LPS challenge dose in the subsequent experiment.

    LPS challenge

    All mice were observed every hour for the first 2448 hours following the lethal LPS challenge. Mice were observed for characteristics of LPS toxicity (ocular exudates, diarrhea, increased respiratory rate) as well as moribund status (inability to sustain body temperature, ataxia or tremors, diaphragmatic breathing). In order to assess recovery, mice were given a score from 03 based on ambulation as an indication of overall health status: 0 = unable to walk, 1= take steps to walk, 2 = able to walk quickly but not run, and 3 = able to run/normal ambulation.

    Author did not specify which List Labs LPS product was utilized in their research.  List Labs provides the following LPS products:  https://listlabs.com/product-information/lipopolysaccharides/

Efficient Neutralization of Antibody-Resistant Forms of Anthrax Toxin by a Soluble Receptor Decoy Inhibitor

Sharma S, Thomas D, Marlett J, Manchester M, Young JA

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Genetic Vaccines for Anthrax Based on Recombinant Adeno-associated Virus Vectors

Liu TH, Oscherwitz J, Schnepp B, Jacobs J, Yu F, Cease KB, Johnson PR

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis